Véronique Debien

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis

Elisa Agostinetto, Mattia Rediti, Danai Fimereli et al. · Cancers · 2021 · 285 citations · Full text

Medicine, Cancer Biology, Oncology +16

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

Laurence Buisseret, Delphine Loirat, Philippe Aftimos et al. · Nature Communications · 2023 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Avelumab as the basis of neoadjuvant regimen in platinum-eligible and -ineligible patients with nonmetastatic muscle-invasive bladder cancer: AURA (Oncodistinct-004) trial.

Nieves Martínez Chanzá, Aurélien Carnot, Philippe Barthélémy et al. · Journal of Clinical Oncology · 2022 · 19 citations

Medicine, Oncology, Urology +14

Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors

Véronique Debien, Guillaume Davidson, Philippe Baltzinger et al. · Cancers · 2021 · 13 citations · Full text

Medicine, Immunology, Oncology +17

DECRESCENDO: De-escalation of adjuvant chemotherapy in patients with HER2+/HR-/node-negative early breast cancer who achieve pCR after neoadjuvant taxane and subcutaneous dual anti-HER2 blockade.

Véronique Debien, Virginie Adam, Rafael Caparica et al. · Journal of Clinical Oncology · 2022 · 10 citations

Medicine, Oncology, Pharmacology +15